The Dow Jones Industrial Average led stocks lower in today's stock market, but rebounded off lows in afternoon trade. Meanwhile, the Nasdaq also narrowed losses with an afternoon bounce.
Dow Jones In The Stock Market Today
The Nasdaq composite pared back to a 0.1% loss as it attempts to avert a fifth straight decline. The Dow Jones held a 0.6% loss, erasing most of its gains from Monday. The S&P 500 traded 0.4% lower, while the Russell 2000 index dropped 0.8%. Data showed lower volume on the NYSE and on the Nasdaq vs. the same time on Monday.
The major indexes traded lower early Tuesday, extending their losses from last week's minor sell-off. Early Tuesday, the Labor Department reported a 0.3% uptick in the August consumer price index. That was lower than July's 0.5% increase and economists' forecasts for a 0.4% advance. On a year-over-year basis, the index was up 5.3%, in line with expectations. The softer-than-forecast price rise suggested inflation increases remained within expectations. But combined with last week's surprise leap in producer prices, the CPI number stirred concerns over tightening corporate margins, according to Edward Moya, senior market analyst at OANDA.
U.S. Stock Market Today Overview |
||||
|---|---|---|---|---|
| Index | Symbol | Price | Gain/Loss | % Change |
| Dow Jones | (0DJIA) | 34631.41 | -238.22 | -0.68 |
| S&P 500 | (0S&P5) | 4451.58 | -17.15 | -0.38 |
| Nasdaq | (0NDQC ) | 15086.27 | -19.31 | -0.13 |
| Russell 2000 | 221.19 | -1.69 | -0.76 | |
| IBD 50 | 49.20 | +0.84 | +1.74 | |
Last Update: 1:26 PM ET 9/14/2021 |
||||
Still, growth stocks rebounded on the stock market. The Innovator IBD 50 ETF gained 1.9%, regaining some of the prior day's losses. The ETF is once again approaching a 50.06 buy point after gaining support at the 21-day exponential moving average. Stocks outperforming in the index included Crocs and Doximity, which rose more than 11% and 8%, respectively.
Shares of Crocs reached a new high in heavy volume. The footwear retailer announced during its annual investor day Tuesday that it projects revenue of over $5 billion by 2026. Analysts' revenue estimates for 2021 are roughly $2.27 billion and $2.48 billion for 2022. This IBD 50 stock is already up over 125% year to date and shows no signs of slowing down.
Elsewhere, growth stock and enterprise computer software firm ZoomInfo Technologies broke out from a flat base with 67.73 buy point. Shares remain inside the key buy area, which extends to 71.12, after rising over 4.5% on Tuesday. The stock recently rebounded from a test of support at its 21-day exponential moving average.
Tuesday's losses came on the heels of a mixed session on Monday. Monday's The Big Picture column commented, "Sellers hit leading growth stocks in the stock market Monday, but the rest of the market held up relatively well, with oil and gas stocks leading the way. Solar stocks also outperformed, along with reopening stocks like airlines and hotel operators, amid signs the delta variant wave could be cresting."
Oil Stocks Pull Back Amid Rally
On Tuesday, crude oil turned negative in midday trading, with West Texas Intermediate futures down 0.3%. But the price still remains above $70 a barrel, a key benchmark for the commodity. Crude oil topped the $70 level for the first time in nearly six weeks on Monday.
The Energy Select Sector SPDR Fund pulled back over 1% on Tuesday after being the top performing S&P sector ETF Monday with a 2.9% increase.
Oil and gas stocks to watch include producer Devon Energy and Magnolia Oil & Gas. Both stocks pulled back Tuesday after Monday's bullish action. Devon Energy is forming a cup-with-handle base with a 30.65 buy point. Meanwhile, Magnolia's relative strength line is approaching a fresh high as the stock trades near a 16.48 entry.
Cimarex Energy, which broke out from a cup-base 76.49 buy point on Monday, pulled back from the buy zone in today's trading. Shares have been powering sharply higher since the end of August. The buy zone tops out at 80.31.
Follow Rachel Fox on Twitter at @foxonstocks for more Dow Jones and market commentary.
